GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (OTCPK:TRUMF) » Definitions » 5-Year EBITDA Growth Rate

TRUMF (Terumo) 5-Year EBITDA Growth Rate : 7.40% (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Terumo 5-Year EBITDA Growth Rate?

Terumo's EBITDA per Share for the three months ended in Dec. 2024 was $0.30.

During the past 12 months, Terumo's average EBITDA Per Share Growth Rate was 23.40% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 13.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Terumo was 17.80% per year. The lowest was -3.60% per year. And the median was 8.90% per year.


Competitive Comparison of Terumo's 5-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Terumo's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Terumo's 5-Year EBITDA Growth Rate falls into.


;
;

Terumo 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Terumo  (OTCPK:TRUMF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Terumo 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Terumo's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Terumo Business Description

Traded in Other Exchanges
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2024, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 36% of Terumo's revenue.